Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.46
Clone:
1C5.1, monoclonal
Species reactivity:
rat, human
Application:
IHC, WB
Citations:
1
Product Name
Anti-Connexin 43 Antibody, CT Antibody, clone 1C5.1, clone 1C5.1, from mouse
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
1C5.1, monoclonal
species reactivity
rat, human
technique(s)
immunohistochemistry: suitable (paraffin), western blot: suitable
isotype
IgG1κ
NCBI accession no.
UniProt accession no.
shipped in
ambient
target post-translational modification
unmodified
Gene Information
human ... GJA1(2697)
General description
Gap junction alpha-1 protein (UniProt P17302; also known as Connexin-43, Cx43, Gap junction 43 kDa heart protein) is encoded by the GJA1 (also known as AVSD3, CMDR, GJAL, HSS, ODDD) gene (Gene ID 2697) in human. A gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexins, through which materials of low molecular weight diffuse from one cell to a neighboring cell. Connexin-43 is a polytopic integral membrane protein oligomerizes into a hexamer or connexon. It is he most ubiquitously expressed connexin and contains a long C-terminal tail, an N-terminal domain, and multiple transmembrane domains. The C-terminal tail domain of human connexin-43 contains 50 amino acids and includes post-translational modification sites, as well as binding sites for transcription factors, cytoskeleton elements, and other proteins. The C-terminal tail regulates pH gating and channel assembly, whereas the N-terminal domain is involved in channel gating and oligomerization and controls the switch between channel open and closed states. Mutations in connexin-43 result in multiple disorders, such as oculodentodigital dysplasia that is characterized by microcornea, microphthalmia, and syndactyly of the fourth and fifth fingers. Connexin-43 is shown to negatively regulate growth of colon cancer cells, in part by enhancing apoptosis. Loss of connexin-43 expression in colorectal cancers is correlated with significantly shorter relapse-free and overall survival.
Ref.:
Sirnes, S et al. (2012). Int. J. Cancer 131, 570-581.
Naus, CC et al. (2010). Nat. Rev. Cancer. 10, 435-441.
Ref.:
Sirnes, S et al. (2012). Int. J. Cancer 131, 570-581.
Naus, CC et al. (2010). Nat. Rev. Cancer. 10, 435-441.
~43 kDa observed. 42.88/42.90 kDa (human/rat) calculated (Met1 removed). Uncharacterized bands may be observed in some lysate(s).
Immunogen
GST-tagged recombinant human connexin 43 C-terminal cytoplasmic tail fragment.
Application
Anti-Connexin 43, CT, clone 1C5.1, Cat. No. MABT528 is a mouse monoclonal antibody validated for use in Immunohistochemistry (Paraffin) and Western Blotting for the detection of connexin 43.
Immunohistochemistry Analysis: A 1:250-1,000 dilution from a representative lot detected cconnexin 43 in human cerebellum, heart muscle, and kidney tissue sections.
Biochem/physiol Actions
Clone 1C5.1 targets an epitope within the second half of the C-terminal cytoplasmic tail.
Physical form
Format: Purified
Analysis Note
Evaluated by Western Blotting in HUVEC lysate.
Western Blotting Analysis: 10 ng/mL of this antibody detected connexin 43 in 10 µg of HUVEC lysate.
Western Blotting Analysis: 10 ng/mL of this antibody detected connexin 43 in 10 µg of HUVEC lysate.
Other Notes
Concentration: Please refer to lot specific datasheet.
Replaces: MAB3068
Still not finding the right product?
Explore all of our products under Anti-Connexin 43 Antibody, CT Antibody, clone 1C5.1
— or —
Try our Product Selector Tool to narrow your options
Storage Class
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Aleksandra V Durkina et al.
Journal of pineal research, 73(1), e12798-e12798 (2022-04-07)
Melatonin treatment was reported to reduce the risk of cardiac arrhythmias, and crucial for this antiarrhythmic action was the effect of melatonin on activation spread. The aim of the present study was evaluation of the mechanisms of this activation enhancement. Experiments
Global Trade Item Number
| SKU | GTIN |
|---|---|
| MABT528 | 04054839114465 |